Friday, 27 November 2015

What You Need to Know About PRK Lasik


PRK LASIK (PHOTOREFRACTIVE KERATECTOMY)


PRK LASIK is generally recommended for patients whose corneas 
are too thin to allow for the creation of the LASIK flap safely. 
PRK LASIK is a refractive surgery in which the central epithelium,
 or surface layer of the cornea, is removed by the surgeon, 
and then the corneal bed is directly reshaped with the laser.
The surgeon may choose to use an anti-inflammatory compound 
Mitomycin C on some patients. Mitomycin C is a powerful 
pharmaceutical agent which inhibits haze in patients 
post PRK Surgery.

 It is highly recommended to use Mitomycin C on all patients with 
greater than -4.00 D prescriptions who are having PRK since these 
patients are at greater risk of the complication of haze formation
 post operatively.

To promote healing and comfort, a bandage 
contact lens is placed on the cornea.
 The corneal epithelium will heal within
 5-6 days in the average patient. 
During this period, it is recommended that 
you are monitored daily by our 
optometrists or your eye care professional 
until the contact lens is removed.
After the contact lens is removed, the follow-ups are
 usually more spaced out. Because there is no flap created,
 restrictions with physical activities are less 
than what is imposed upon LASIK patients.
Myopia (nearsightedness), hyperopia (farsightedness) and 
astigmatism can be treated using PRK. Again, presbyopia 
cannot be corrected by excimer laser treatments.
If you are having PRK, it probably means your corneas are
 thinner than average, your prescription is higher or both.

Dr. Andrew W. Taylor, MD, FRCSC, Dip ABO 
is a cum laude graduate of the University
 of Toronto. He received his medical degree
from the University of Toronto in 1991,
completed an internship in comprehensive
internal medicine at The Toronto Hospital at
 the University of Toronto in 1992, then went
on to complete his residency training in 
ophthalmology at the University of Toronto.
He received his Fellowship from the Royal
 College of Surgeons of Canada in 1995, 
became a Diplomat of the American Board of Ophthalmology in 1997, and was the recipient
 of numerous academic awards including the Dr. Louis Kagal Memorial 
Award for excellence in ophthalmology from the University of Toronto,
 Faculty of Medicine.

Dr. Taylor has been in private practice since 1995, specializing in 
anterior segment and refractive surgery. He is associated with Peninsula
 Eye Associates in Niagara Falls and is the former Chief of Ophthalmology
at the Greater Niagara General Hospital.

Performing laser refractive surgery since 1995, with extensive 
experience in LASIK, PRK and intraocular surgery, he has also
participated as an investigator on previous FDA trials of new technologies in refractive surgery. Performing over 80,000 refractive  procedures,
including over 10,000 custom wavefront ablations since 2001,
Dr. Taylor founded LASIK PROVISION and is acting Medical Director
of the clinic.

Active member of the Ontario Medical Association, the Canadian Medical Association, the College of Physicians and Surgeons of Ontario, the
Royal College of Physicians of Canada, the American Board of
Ophthalmology, the American Academy of Ophthalmology,
the American Society of Cataract and Refractive Surgeons and the 
International Society of Refractive Surgery.

No comments:

Post a Comment